Fracture (FX) Improvement With Teriparatide: FiX-IT Study

Trial Profile

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Fracture; Postmenopausal osteoporosis
  • Focus Biomarker; Therapeutic Use
  • Acronyms FiX-IT
  • Most Recent Events

    • 05 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 25 Apr 2016 Status changed from recruiting to active, no longer recruiting.
    • 10 Jun 2015 Planned End Date changed from 1 Nov 2016 to 1 Jun 2017, as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top